DrugPatentWatch Database Preview
La Jolla Pharma Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for LA JOLLA PHARMA, and when can generic versions of LA JOLLA PHARMA drugs launch?
LA JOLLA PHARMA has one approved drug.
There are eight US patents protecting LA JOLLA PHARMA drugs.
There are sixteen patent family members on LA JOLLA PHARMA drugs in nineteen countries.
Summary for La Jolla Pharma
| International Patents: | 16 |
| US Patents: | 8 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for La Jolla Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-001 | Dec 21, 2017 | RX | Yes | Yes | 9,572,856 | Start Trial | Start Trial | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-001 | Dec 21, 2017 | RX | Yes | Yes | 10,500,247 | Start Trial | Start Trial | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-001 | Dec 21, 2017 | RX | Yes | Yes | 10,028,995 | Start Trial | Start Trial | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-002 | Dec 21, 2017 | DISCN | Yes | No | 10,028,995 | Start Trial | Start Trial | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-002 | Dec 21, 2017 | DISCN | Yes | No | 9,220,745 | Start Trial | Start Trial | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-001 | Dec 21, 2017 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-002 | Dec 21, 2017 | DISCN | Yes | No | 10,335,451 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for La Jolla Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 106061493 | Start Trial |
| Canada | 2933601 | Start Trial |
| Slovenia | 2986308 | Start Trial |
| Israel | 246162 | Start Trial |
| Croatia | P20200009 | Start Trial |
| European Patent Office | 2986308 | Start Trial |
| Lithuania | 2986308 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
